Patient Guide: Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05536973
Status: ACTIVE_NOT_RECRUITING
Condition: Neovascular Age-related Macular Degeneration
Phase: PHASE2

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Phoenix, Arizona
  • • Tucson, Arizona
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] - Join Clinical Trial NCTNCT05536973

How to Join This Clinical Trial - NCTNCT05536973

Learn how to participate in this PHASE2 trial studying an investigational therapy for Neovascular Age-related Macular Degeneration. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neovascular Age-related Macular Degeneration. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neovascular Age-related Macular Degeneration
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05536973 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85020 - United States

Status: Contact for availability

Clinical Research Site

Phoenix, Arizona 85053 - United States

Status: Contact for availability

Clinical Research Site

Tucson, Arizona 85704 - United States

Status: Contact for availability

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: Contact for availability

Clinical Research Site

Encino, California 91436 - United States

Status: Contact for availability

Clinical Research Site

Fullerton, California 92835 - United States

Status: Contact for availability

Clinical Research Site

Pasadena, California 91105 - United States

Status: Contact for availability

Clinical Research Site

Poway, California 92064 - United States

Status: Contact for availability

Clinical Research Site

Riverside, California 92505 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Neovascular Age-related Macular Degeneration:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships